Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
22 May 2024
Long-Term Outcomes of Pulmonary Embolism in Children and Adolescents
A recent cohort study shed light on the long-term consequences of pulmonary embolism in children
9 May 2024
Specialised Follow-up May Be Unnecessary for Low-Risk Chronic Leukaemia
Study shows it is feasible and safe to end specialised follow-up for patients with chronic lymphocytic leukaemia, optimising resources, maintaining survival rates, and reducing hospital visits.
9 May 2024
Stem Cell Transplants Show Improved Survival Rates Across Ethnic Groups
Researchers have revealed significant advancements in haematopoietic cell transplants . While overall survival rates have improved, a stark disparity across diverse racial and ethnic populations persists.
2 May 2024
Predictors of Delayed Platelet Engraftment in Patients with Non-Hodgkin Lymphoma
DELAYED platelet engraftment (PE) post-autologous stem cell transplantation (ASCT) in patients with non-Hodgkin lymphoma (NHL) can lead to severe outcomes…
2 May 2024
Discrepancies in Treatment of Myelofibrosis Across Treatment Centres
HEALTHCARE professionals are lacking guidance with regard to treating myelofibrosis (MF) with secondary portal hypertension (PHT) or pulmonary hypertension (PH)…
2 May 2024
Improving Quality of Life of Patients with Multiple Sclerosis
AUTOLOGOUS haematopoietic stem cell transplantation (ASCT) can improve the quality of life (QoL) of patients with multiple sclerosis (MS)…
2
Mins
2 May 2024
Review of the 50th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
THERE was no better place to celebrate the 50th anniversary of the European Society for Blood and Marrow Transplantation (EBMT) than Glasgow, UK…
5
Mins
25 Apr 2024
Interview: Niamh O'Connell
When I was a medical student in the small university city of Cork, in Ireland, there was one female consultant, and she was a haematologist…
Loading posts...
« Previous
1
…
46
47
48
49
50
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View